The International Society of Gastrointestinal Oncology (ISGIO), a not-for-profit global educational organization committed to GI oncology, announces that Weijing Sun, MD, FACP, has been elected the society’s next leader.
First patient enrolled at The University of Kansas Cancer Center in expansion cohort study characterizing the safety, pharmacokinetics and pharmacodynamics of fosciclopirox in bladder cancer patients
Ronald Chen, MD, MPH, has been named the Brandmeyer Chair and Professor of Radiation Oncology at the University of Kansas School of Medicine, clinical service chief at The University of Kansas Health System and associate director for Health Equity at T…
The University of Kansas Cancer Center and Midwest Cancer Alliance have been awarded a grant to expand the reach of cancer clinical trials to Kansas’ rural communities.
Clinical health psychology fellowship emphasizes psychological care for people with cancer.
Researchers from The University of Kansas Cancer Center has received a five-year, $2.25 million grant from the National Cancer Institute to study why there are survival rate disparities in rural parts of Kansas, and how to improve them.
A select group of early-career investigators has been selected to be a part of the University of Kansas Medical Center’s $11.5 million precision medicine-focused federal grant.
A new program seeks to improve community oncology providers’ knowledge of genetic testing in ****** cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.
Scott Weir, Pharm.D., Ph.D., of The University of Kansas Cancer Center, is the recipient of the 2018 Janet Davison Rowley Patient Impact Research Award. Dr. Weir serves as director of the Institute for Advancing Medical Innovation (IAMI) and as associa…
The University of Kansas Cancer Center was recently recognized as a “high-performing site” by the National Cancer Institute (NCI).